| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
Access across
the world
Evidence-based testing for the detection and identification of infectious diseases
Mayo Clinic’s internationally renowned clinical microbiology laboratories span all areas of conventional and molecular medical microbiology, offering a broad selection of tests designed for rapid identification and in-depth characterization of the causative agents of infectious diseases.
Our laboratories have developed and implemented culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular methods for rapid detection, identification, and characterization, as well as provision treatment guidance for microbial pathogens.
Results that matter
We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.
3 million
tests performed annually
70
years of diagnosing and treating infectious diseases
7
specialized laboratories performing infectious disease testing
24/7
support from Mayo Clinic physicians and scientists
Physician-led subspecialized laboratories
Our laboratories are managed by physicians and scientists with expert knowledge regarding the clinical implications of each test result and how it can impact patient care.
The right tests, not the most tests
Our clinicians and laboratorians focus on maintaining high-quality, cost-effective, and efficient care by using algorithmic, evidence-based approaches that lead to correct diagnoses and treatment while minimizing unnecessary testing.
Access across
the globe
Every laboratory offers testing. But at Mayo Clinic Laboratories, in addition to our comprehensive testing menu, we offer a service that allow patients access to Mayo Clinic experts from across the world.
COVID-19 Resource Center
We are rapidly expanding our COVID-19 testing to provide accurate information for health care professionals on the front lines of this crisis. We will continue coordinating closely with state and federal officials to offer testing in the areas with the greatest need.
The Latest
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, talk about West Nile virus and why laboratories and the public need to be aware as mosquitoes reemerge.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, discuss endemic fungal infections that can be found in North America, specifically blastomycosis and histoplasmosis.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Nancy Wengenack, Ph.D., director of the Mycology and Mycobacteriology Laboratories at Mayo Clinic, discuss the increased focus on fungi and why emerging fungal infections can be concerning for health care facilities.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, discuss the increasing rates of tick-borne diseases and how to test for and prevent them. They also discuss what to watch from a federal legislative standpoint now that Congress is back in session.
Host Bobbi Pritt, M.D., is joined by Robin Patel, M.D., co-director of the Clinical Bacteriology Laboratory at Mayo Clinic and director of the Mayo Clinic Infectious Diseases Research Laboratory, for a discussion on the rising cases and reports of group A streptococcus and antibiotic resistant gonorrhea across the United States.